Intellectual Property Law and Copyright Laws

On June 8, 2012, Genentech’s lawsuit seeking a declaration that US Patent No. 6,733,752 was invalid and not-infringed by Genentech’s trastuzumab product (HERCEPTIN).

Health Canada specifically contemplates certain proteins as SEBs in its Guidance, although Health Canada has not limited SEBs to only particular classes of drugs.

On May 23, 2012, the Federal Court held that Merck Frosst Canada Ltd. ("Merck") is liable to Apotex Inc. ("Apotex") for damages under section 8 of the Patented Medicines (Notice of Compliance) Regulations (the "Regulations"), but exercised its discretion to reduce the amount of compensation payable based on a defence of ex turpi causa.

This paper summarizes selected developments in Internet law that occurred in 2010.

Environmental investigators are not allowed to seize private documents unless they have prior judicial authorization (i.e., a search warrant) or the consent of the owner of the documents.

On October 22, 2010, an American magistrate judge ruled that a plaintiff suing Universal Music Corp. for improperly sending a takedown notice under the Digital Millennium Copyright Act (DMCA) waived a number of heads of attorney-client privilege by discussing the details of her legal case by email and on a blog.

In recent years, local trademarks and products have been attracting growing interest from consumers. This trend can be explained by the ability of local players to better understand...

Depuis quelques années, les marques et produits locaux suscitent un intérêt croissant auprès des consommateurs. Cette tendance s'explique notamment par la capacité des acteurs...

En réponse directe aux commentaires reçus et à l'évolution des besoins des entreprises d'innovation de l'Ontario en matière de propriété intellectuelle, Propriété intellectuelle Ontario (PIO) a annoncé deux...

On June 19, 2025, Canada's Drug Agency (CDA) opened a public consultation on a proposed process for preparing a list of essential prescription drugs and related products.

Patentees and licensors should enforce their patent rights as quickly as they can to avoid possible issues of conflicting limitation periods.

For companies and counsel navigating intellectual property enforcement across borders, it's critical to understand how litigation strategies vary between jurisdictions.